glp 1 or tirzepatide Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs Bridging the gap between GLP1-receptor

15 As such, GIP, secreted by enteroendocrine K-cells, and GLP-1, released from corresponding intestinal L-cells, collectively referred to as the incretin hormones, are well-studied for their roles in glucose homeostasis and energy balance

Garber, A., Henry, R., Ratner, R., Garcia-Hernandez, P

2,3 Prior research has shown mixed results for patients metabolic rebound, with some showing weight gain after stopping GLP-1s and others showing weight maintenance

This approach lacks robust clinical trial data but has theoretical appeal for cost management and side effect reduction

More studies are required in order to extend our knowledge and understand the effects of GLP1-RAs on neurological complications of diabetes

Circulating glucagon after total pancreatectomy in man